Common Stock KINDRED BIOSCIENCES, INC. FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • March 18th, 2014 • Kindred Biosciences, Inc. • Pharmaceutical preparations • New York
Kindred Biosciences, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [•] shares (the “Firm Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”). The Company also proposes to issue and sell to the several Underwriters up to an additional [•] shares (the “Additional Shares”) of Common Stock at the option of the Underwriters as provided in Section 2(c) below. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the “Shares”. Leerink Partners LLC, BMO Capital Markets Corp. and Guggenheim Securities, LLC are acting as the representatives (the “Representatives”) of the several Underwriters in connection with the offering and sale of the Shares contemplated herein (the “Offering”). For purposes of this A
